JP2015506966A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506966A5
JP2015506966A5 JP2014556029A JP2014556029A JP2015506966A5 JP 2015506966 A5 JP2015506966 A5 JP 2015506966A5 JP 2014556029 A JP2014556029 A JP 2014556029A JP 2014556029 A JP2014556029 A JP 2014556029A JP 2015506966 A5 JP2015506966 A5 JP 2015506966A5
Authority
JP
Japan
Prior art keywords
formula
compound
tautomer
protecting group
group selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014556029A
Other languages
English (en)
Japanese (ja)
Other versions
JP6105631B2 (ja
JP2015506966A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/052287 external-priority patent/WO2013117568A1/de
Publication of JP2015506966A publication Critical patent/JP2015506966A/ja
Publication of JP2015506966A5 publication Critical patent/JP2015506966A5/ja
Application granted granted Critical
Publication of JP6105631B2 publication Critical patent/JP6105631B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014556029A 2012-02-09 2013-02-06 1,4−保護9−ヒドロキシ−5−オキソ−1,4−ジアザ−スピロ[5.5]ウンデカンの立体選択的合成方法 Active JP6105631B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12154688.1 2012-02-09
EP12154688 2012-02-09
PCT/EP2013/052287 WO2013117568A1 (de) 2012-02-09 2013-02-06 Verfahren zur stereoselektiven synthese von 1,4-geschützten 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecane

Publications (3)

Publication Number Publication Date
JP2015506966A JP2015506966A (ja) 2015-03-05
JP2015506966A5 true JP2015506966A5 (enExample) 2016-03-24
JP6105631B2 JP6105631B2 (ja) 2017-03-29

Family

ID=47678813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014556029A Active JP6105631B2 (ja) 2012-02-09 2013-02-06 1,4−保護9−ヒドロキシ−5−オキソ−1,4−ジアザ−スピロ[5.5]ウンデカンの立体選択的合成方法

Country Status (14)

Country Link
US (1) US8629146B2 (enExample)
EP (1) EP2812317B1 (enExample)
JP (1) JP6105631B2 (enExample)
KR (1) KR20140128318A (enExample)
CN (1) CN104080775A (enExample)
AU (1) AU2013218119A1 (enExample)
BR (1) BR112014019196A8 (enExample)
CA (1) CA2862520A1 (enExample)
CL (1) CL2014001823A1 (enExample)
EA (1) EA201400882A1 (enExample)
IL (1) IL233370A (enExample)
MX (1) MX2014009033A (enExample)
PH (1) PH12014501760A1 (enExample)
WO (1) WO2013117568A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289881A1 (de) * 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
ATE557008T1 (de) 2002-03-30 2012-05-15 Boehringer Ingelheim Pharma 4- ( n-phenylamino ) -chinazoline/chinoline als tyrosinkinaseinhibitoren
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
CA2631813A1 (en) 2005-12-12 2007-06-21 Boehringer Ingelheim International Gmbh Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
PT2245026E (pt) 2008-02-07 2012-10-15 Boehringer Ingelheim Int Heterociclos espirocíclicos, produtos farmacêuticos contendo estes compostos, sua utilização e processo para a sua preparação
EP2289881A1 (de) 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen
PE20141012A1 (es) * 2011-02-01 2014-09-10 Boehringer Ingelheim Int Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparacion

Similar Documents

Publication Publication Date Title
JP2011518833A5 (enExample)
JP2019048806A5 (enExample)
JP2010095546A5 (enExample)
JP2010500343A5 (enExample)
JP2009535462A5 (enExample)
JP2009120624A5 (enExample)
JP2017222697A5 (enExample)
JP2016520672A5 (enExample)
JP2010174033A5 (enExample)
JP2013032389A5 (enExample)
JP2013532130A5 (enExample)
JP2010501534A5 (enExample)
JP2009138000A5 (enExample)
JP2015042636A5 (ja) 有機化合物
JP2014526533A5 (enExample)
JP2011524871A5 (enExample)
JP2009256615A5 (enExample)
JP2015524822A5 (enExample)
RU2012111227A (ru) Получение нейростимулирующего пиперазина
JP2016513122A5 (enExample)
JP2007526383A5 (enExample)
JP2010534246A5 (enExample)
JP2011016798A5 (enExample)
JP2018009003A5 (enExample)
JP2013100237A5 (enExample)